MBX
MBX Biosciences, Inc. Common Stock
NASDAQ: MBX · HEALTHCARE · BIOTECHNOLOGY
$30.22
+5.63% today
Updated 2026-04-30
Market cap
$1.38B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.38
Dividend yield
—
52W range
$9 – $45
Volume
0.5M
MBX Biosciences, Inc. Common Stock (MBX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-23.12M | $-31.98M | $-54.68M | $-79.95M |
| Capital expenditures | $441000.00 | $129000.00 | $874000.00 | $1.93M |
| Depreciation | — | — | — | — |
| Stock-based comp | $306000.00 | $2.04M | $5.22M | $8.68M |
| Free cash flow | $-23.56M | $-32.11M | $-55.55M | $-81.88M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |